Alder raises $200M in follow-on

Alder Biopharmaceuticals Inc. (NASDAQ:ALDR) raised $200 million through the sale of 4.5 million shares at $44.50 in a follow-on underwritten by Credit Suisse; Leerink; Wells Fargo; and Bernstein. Alder proposed the offering after market close on Wednesday, when its share price was $49.82.

The follow-on is Alder's second of 2015. It raised $203.6 million in January. ...